Codexis Inc (CDXS)
2.80
-0.10
(-3.45%)
USD |
NASDAQ |
Apr 24, 16:00
2.81
+0.01
(+0.36%)
After-Hours: 20:00
Codexis Revenue (TTM): 70.14M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 70.14M |
| September 30, 2023 | 73.96M |
| June 30, 2023 | 99.15M |
| March 31, 2023 | 116.23M |
| December 31, 2022 | 138.59M |
| September 30, 2022 | 132.72M |
| June 30, 2022 | 135.02M |
| March 31, 2022 | 122.06M |
| December 31, 2021 | 104.76M |
| September 30, 2021 | 101.29M |
| June 30, 2021 | 82.90M |
| March 31, 2021 | 72.42M |
| December 31, 2020 | 69.06M |
| September 30, 2020 | 66.67M |
| June 30, 2020 | 70.19M |
| March 31, 2020 | 67.54M |
| December 31, 2019 | 68.46M |
| September 30, 2019 | 65.88M |
| June 30, 2019 | 60.92M |
| March 31, 2019 | 62.14M |
| December 31, 2018 | 60.59M |
| September 30, 2018 | 66.25M |
| June 30, 2018 | 59.29M |
| March 31, 2018 | 56.10M |
| December 31, 2017 | 50.02M |
| Date | Value |
|---|---|
| September 30, 2017 | 38.27M |
| June 30, 2017 | 43.16M |
| March 31, 2017 | 48.81M |
| December 31, 2016 | 48.84M |
| September 30, 2016 | 50.45M |
| June 30, 2016 | 52.98M |
| March 31, 2016 | 43.00M |
| December 31, 2015 | 41.80M |
| September 30, 2015 | 44.41M |
| June 30, 2015 | 34.48M |
| March 31, 2015 | 35.03M |
| December 31, 2014 | 35.31M |
| September 30, 2014 | 30.64M |
| June 30, 2014 | 27.11M |
| March 31, 2014 | 27.52M |
| December 31, 2013 | 31.92M |
| September 30, 2013 | 30.31M |
| June 30, 2013 | 52.71M |
| March 31, 2013 | 68.64M |
| December 31, 2012 | 88.30M |
| September 30, 2012 | 113.88M |
| June 30, 2012 | 120.82M |
| March 31, 2012 | 123.97M |
| December 31, 2011 | 123.86M |
| September 30, 2011 | 120.18M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
60.92M
Minimum
Jun 2019
138.59M
Maximum
Dec 2022
90.42M
Average
73.96M
Median
Sep 2023
Revenue (TTM) Benchmarks
| Sutro Biopharma Inc | 153.73M |
| Avidity Biosciences Inc | 9.56M |
| Taysha Gene Therapies Inc | 15.45M |
| Janux Therapeutics Inc | 8.083M |
| Tango Therapeutics Inc | 36.53M |